| Financial Year |
March 31 2023 |
| Monetary Funds |
1,488,853,680.83 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,300,000.00 |
| Accounts Receivable |
47,803,652.10 |
| Advances to Suppliers |
44,974,612.55 |
| Other Receivables |
18,678,550.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
780,169,388.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,268,888.36 |
| Total Current Assets |
2,440,061,954.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
240,414,264.46 |
| Investment Properties |
74,425,210.94 |
| Fixed Assetes |
91,685,780.95 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,531,003.66 |
| R&D expenses |
9,914,791.55 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
4,621,472.12 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
470,937,486.53 |
| Total Assets |
2,910,999,441.43 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,496,874.80 |
| Accounts Payable |
219,401,443.59 |
| Accounts Received In Advance |
827,713.07 |
| Employee Compensation Payable |
39,991,706.77 |
| Taxes Payable |
9,109,012.45 |
| Interest Payable |
-- |
| Dividend Payable |
694,746.60 |
| Other payables |
25,745,041.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,863,341.96 |
| Other Current Liabilities |
1,473,264.80 |
| Sub-Total of Current Liabilities |
1,349,334,084.74 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
58,023,863.05 |
| Total Liabilities |
1,407,357,947.79 |
| Paid-In Capital(Or Share Stock) |
371,904,560.00 |
| Capital Surplus |
48,579,107.94 |
| Surplus Reserve |
117,047,265.76 |
| LESS:Treasury Stock |
13,423,388.40 |
| Undistributed Profits |
979,517,151.94 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,503,641,493.64 |
| Owner's Equity（Stockholder's Equity） |
1,503,641,493.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,910,999,441.43 |
